AstraZeneca AB

Sweden

Back to Profile

1-100 of 182 for AstraZeneca AB Sort by
Query
Trademark
Canada - CIPO
Excluding Subsidiaries
Aggregations Reset Report
Date
New (last 4 weeks) 3
2024 April (MTD) 3
2024 January 1
2024 (YTD) 4
2023 4
See more
NICE Class
05 - Pharmaceutical, veterinary and sanitary products 163
44 - Medical, veterinary, hygienic and cosmetic services; agriculture, horticulture and forestry services 12
41 - Education, entertainment, sporting and cultural services 11
10 - Medical apparatus and instruments 9
42 - Scientific, technological and industrial services, research and design 6
See more
Status
Pending 34
Registered / In Force 148
Found results for  trademarks
  1     2        Next Page

1.

EVSTANZA

      
Application Number 232263100
Status Pending
Filing Date 2024-04-19
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 00 - No classifiable goods/services

Goods & Services

(1) Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection and inflammation; Pharmaceutical preparations and substances for the treatment of hematological, autoimmune, and immune-mediated diseases and disorders; Pharmaceutical preparations and substances, namely, pharmaceutical antibodies for neutralizing viruses; vaccines for humans.

2.

KAMVIDRA

      
Application Number 232265400
Status Pending
Filing Date 2024-04-19
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 00 - No classifiable goods/services

Goods & Services

(1) Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection and inflammation; Pharmaceutical preparations and substances for the treatment of hematological, autoimmune, and immune-mediated diseases and disorders; Pharmaceutical preparations and substances, namely, pharmaceutical antibodies for neutralizing viruses; vaccines for humans.

3.

OCAMLAH

      
Application Number 232264700
Status Pending
Filing Date 2024-04-19
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 00 - No classifiable goods/services

Goods & Services

(1) Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection and inflammation; Pharmaceutical preparations and substances for the treatment of hematological, autoimmune, and immune-mediated diseases and disorders; Pharmaceutical preparations and substances, namely, pharmaceutical antibodies for neutralizing viruses; vaccines for humans.

4.

FASENRA

      
Application Number 230710500
Status Pending
Filing Date 2024-01-26
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for the treatment of immune-mediated inflammatory diseases and disorders

5.

WAINUA

      
Application Number 229610000
Status Pending
Filing Date 2023-10-24
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for the treatment of amyloidosis.

6.

WW

      
Application Number 232074700
Status Pending
Filing Date 2023-10-19
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances.

7.

AIRSIPRIA

      
Application Number 228926600
Status Pending
Filing Date 2023-09-20
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances.

8.

AIRZUPRA

      
Application Number 228926800
Status Pending
Filing Date 2023-09-20
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances.

9.

CAMGOSERD

      
Application Number 223007700
Status Pending
Filing Date 2022-12-22
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

10.

CAMKARM

      
Application Number 223007100
Status Pending
Filing Date 2022-12-22
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

11.

CAVTHYSTA

      
Application Number 222557500
Status Pending
Filing Date 2022-11-07
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances.

12.

KAVCAPA

      
Application Number 222557600
Status Pending
Filing Date 2022-11-07
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances.

13.

Geometric Shape Design

      
Application Number 222979200
Status Pending
Filing Date 2022-11-07
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances.

14.

TRUQAP

      
Application Number 220027300
Status Pending
Filing Date 2022-07-26
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

15.

FORXIGA

      
Application Number 218483300
Status Pending
Filing Date 2022-05-11
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for the treatment and prevention of diseases and disorders of the renal system; pharmaceutical preparations and substances for the treatment and prevention of disorders of the cardiovascular and metabolic systems

16.

IRELYMI

      
Application Number 217717100
Status Pending
Filing Date 2022-04-05
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for the treatment of amyloidosis

17.

IPPVI

      
Application Number 217708800
Status Pending
Filing Date 2022-04-05
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for the treatment of amyloidosis

18.

AKTALEST

      
Application Number 213869300
Status Registered
Filing Date 2021-09-09
Registration Date 2023-07-26
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, respiratory, and gastrointestinal systems; Pharmaceutical preparations and substances for the treatment of metabolic diseases and disorders, namely anemia, arthritis, diabetes, gout, hyperlipidemia, hypoglycaemia, hypothyroidism, insulin resistance, metabolic syndrome, muscular dystrophy, obesity, osteoarthritis; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the nervous system, namely autonomic neuropathies, cranial and spinal neuropathies, sensorimotor neuropathies and plexopathies, Alzheimer's, brain diseases, central nervous system infections, central nervous system movement disorders, cerebral palsy, encephalitis, epilepsy, ocular motility disorders, Parkinson's disease, spinal cord diseases; Pharmaceutical preparations and substances for the treatment of infection, namely anti-invectives; Pharmaceutical preparations and substances for the treatment of inflammation, namely anti-inflammatories.

19.

KYTALA

      
Application Number 213707200
Status Registered
Filing Date 2021-09-09
Registration Date 2023-07-26
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, respiratory, and gastrointestinal systems; Pharmaceutical preparations and substances for the treatment of metabolic diseases and disorders, namely anemia, arthritis, diabetes, gout, hyperlipidemia, hypoglycaemia, hypothyroidism, insulin resistance, metabolic syndrome, muscular dystrophy, obesity, osteoarthritis; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the nervous system, namely autonomic neuropathies, cranial and spinal neuropathies, sensorimotor neuropathies and plexopathies, Alzheimer's, brain diseases, central nervous system infections, central nervous system movement disorders, cerebral palsy, encephalitis, epilepsy, ocular motility disorders, Parkinson's disease, spinal cord diseases; Pharmaceutical preparations and substances for the treatment of infection, namely anti-invectives; Pharmaceutical preparations and substances for the treatment of inflammation, namely anti-inflammatories.

20.

CAVIVA

      
Application Number 213202400
Status Pending
Filing Date 2021-09-08
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, gastrointestinal systems; Pharmaceutical preparations and substances for the treatment of infections and inflammation

21.

ORPATHYS

      
Application Number 213549600
Status Registered
Filing Date 2021-07-29
Registration Date 2023-07-26
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology

22.

Curved lines design

      
Application Number 213549700
Status Registered
Filing Date 2021-07-29
Registration Date 2023-07-26
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology

23.

POVNUZA

      
Application Number 213545200
Status Registered
Filing Date 2021-07-28
Registration Date 2023-07-26
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, respiratory, and gastrointestinal systems; Pharmaceutical preparations and substances for the treatment of metabolic diseases and disorders, namely anemia, arthritis, diabetes, gout, hyperlipidemia, hypoglycaemia, hypothyroidism, insulin resistance, metabolic syndrome, muscular dystrophy, obesity, osteoarthritis; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the nervous system, namely autonomic neuropathies, cranial and spinal neuropathies, sensorimotor neuropathies and plexopathies, Alzheimer's, brain diseases, central nervous system infections, central nervous system movement disorders, cerebral palsy, encephalitis, epilepsy, ocular motility disorders, Parkinson's disease, spinal cord diseases; Pharmaceutical preparations and substances for the treatment of infection, namely anti-invectives; Pharmaceutical preparations and substances for the treatment of inflammation, namely anti-inflammatories.

24.

MEVPAFA

      
Application Number 213547000
Status Registered
Filing Date 2021-07-28
Registration Date 2023-07-26
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, respiratory, and gastrointestinal systems; Pharmaceutical preparations and substances for the treatment of metabolic diseases and disorders, namely anemia, arthritis, diabetes, gout, hyperlipidemia, hypoglycaemia, hypothyroidism, insulin resistance, metabolic syndrome, muscular dystrophy, obesity, osteoarthritis; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the nervous system, namely autonomic neuropathies, cranial and spinal neuropathies, sensorimotor neuropathies and plexopathies, Alzheimer's, brain diseases, central nervous system infections, central nervous system movement disorders, cerebral palsy, encephalitis, epilepsy, ocular motility disorders, Parkinson's disease, spinal cord diseases; Pharmaceutical preparations and substances for the treatment of infection, namely anti-invectives; Pharmaceutical preparations and substances for the treatment of inflammation, namely anti-inflammatories.

25.

IMJUDO

      
Application Number 212532900
Status Registered
Filing Date 2021-07-01
Registration Date 2023-07-26
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology.

26.

Miscellaneous Design

      
Application Number 208320900
Status Pending
Filing Date 2021-02-08
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, gastrointestinal systems; Pharmaceutical preparations and substances for the treatment of infections and inflammation

27.

YUTRIVO

      
Application Number 207892400
Status Pending
Filing Date 2020-12-01
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances.

28.

AEROSPHERE

      
Application Number 207365000
Status Registered
Filing Date 2020-11-24
Registration Date 2022-08-10
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 10 - Medical apparatus and instruments

Goods & Services

(1) Medical devices, namely, inhalers prefilled with pharmaceuticals; but not including holding chambers or spacers for prefilled inhalers.

29.

PERSONIFIED GEOMETRICAL FIGURES DESIGN

      
Application Number 206815300
Status Registered
Filing Date 2020-10-28
Registration Date 2023-11-01
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances for the treatment of infectious diseases, namely, respiratory infections, inflammation and inflammatory diseases, namely, Lupus; Pharmaceutical preparations and substances, namely, pharmaceutical antibodies for use as anti-infectives, and for use as anti-inflammatories; Pharmaceutical preparations and substances, namely, pharmaceutical antibody preparations for autoimmune diseases, respiratory diseases.

30.

IMFIT

      
Application Number 206505100
Status Registered
Filing Date 2020-10-08
Registration Date 2022-07-06
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 42 - Scientific, technological and industrial services, research and design

Goods & Services

(1) Software as a service (SaaS) providing on-line, non-downloadable, Internet-based software application featuring computer software for use in medical treatment of diseases, namely, software for analyzing patient medical data and providing clinical interpretation to support physicians' treatment decisions.

31.

LEMNYRUS

      
Application Number 204413400
Status Registered
Filing Date 2020-06-24
Registration Date 2022-12-28
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

32.

EFTEMLY

      
Application Number 204413500
Status Registered
Filing Date 2020-06-24
Registration Date 2022-12-28
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

33.

KOSELUGO

      
Application Number 204276100
Status Registered
Filing Date 2020-05-22
Registration Date 2023-11-01
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for the treatment of oncological diseases and disorders for human use only; pharmaceutical preparations and substances for the treatment of neurological diseases and disorders for human use only, namely, neurofibromatosis

34.

WYZEDO

      
Application Number 202840800
Status Pending
Filing Date 2020-05-14
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, gastrointestinal systems; Pharmaceutical preparations and substances for the treatment of anaemia; Pharmaceutical preparations and substances for the treatment of infections and inflammation

35.

JUPZARI

      
Application Number 202841500
Status Pending
Filing Date 2020-05-14
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, gastrointestinal systems; Pharmaceutical preparations and substances for the treatment of anaemia; Pharmaceutical preparations and substances for the treatment of infections and inflammation

36.

LUMEVARZ

      
Application Number 202843800
Status Pending
Filing Date 2020-05-14
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances

37.

SAPHNELO

      
Application Number 202848600
Status Pending
Filing Date 2020-05-14
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances

38.

AIRVIKTO

      
Application Number 202205200
Status Pending
Filing Date 2020-04-09
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, gastrointestinal systems; Pharmaceutical preparations and substances for the treatment of infections and inflammation

39.

AIRSEEKA

      
Application Number 202205300
Status Pending
Filing Date 2020-04-09
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, gastrointestinal systems; Pharmaceutical preparations and substances for the treatment of infections and inflammation

40.

AIRSUPRA

      
Application Number 202205400
Status Pending
Filing Date 2020-04-09
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, gastrointestinal systems; Pharmaceutical preparations and substances for the treatment of infections and inflammation

41.

TRIXEO

      
Application Number 201985200
Status Pending
Filing Date 2020-03-26
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances

42.

HIFZO

      
Application Number 199227300
Status Pending
Filing Date 2019-10-24
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, gastrointestinal systems; Pharmaceutical preparations and substances for the treatment of anaemia; Pharmaceutical preparations and substances for the treatment of infections and inflammation

43.

UHIFZO

      
Application Number 199228600
Status Pending
Filing Date 2019-10-24
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, gastrointestinal systems; Pharmaceutical preparations and substances for the treatment of anaemia; Pharmaceutical preparations and substances for the treatment of infections and inflammation

44.

OHIFZO

      
Application Number 199227700
Status Pending
Filing Date 2019-10-24
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, gastrointestinal systems; Pharmaceutical preparations and substances for the treatment of anaemia; Pharmaceutical preparations and substances for the treatment of infections and inflammation

45.

HIFROCZI

      
Application Number 199228500
Status Pending
Filing Date 2019-10-24
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, gastrointestinal systems; Pharmaceutical preparations and substances for the treatment of anaemia; Pharmaceutical preparations and substances for the treatment of infections and inflammation

46.

VOKESELU

      
Application Number 198881000
Status Pending
Filing Date 2019-10-07
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, gastrointestinal systems; Pharmaceutical preparations and substances for the treatment of infections and inflammation

47.

KOSELUGO

      
Application Number 198881900
Status Pending
Filing Date 2019-10-07
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, gastrointestinal systems; Pharmaceutical preparations and substances for the treatment of infections and inflammation

48.

TRIGZALTO

      
Application Number 196532100
Status Registered
Filing Date 2019-05-28
Registration Date 2023-01-09
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in oncology; pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, respiratory, and gastrointestinal systems; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations and substances for the treatment of infection, namely anti-infective, and for the treatment of inflammation, namely anti-inflammatories.

49.

FASENRA PEN

      
Application Number 195300900
Status Registered
Filing Date 2019-03-22
Registration Date 2023-09-07
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for the prevention and treatment of respiratory diseases and disorders.

50.

HIFENZO

      
Application Number 193974700
Status Registered
Filing Date 2019-01-09
Registration Date 2022-11-11
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of cardiovascular diseases and disorders, metabolic diseases and disorders, in particular, anemia and associated anemia diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, central and peripheral nervous systems diseases and disorders, infection, namely, anti-infectives and inflammation, namely, anti-inflammatories

51.

KEDANSIL

      
Application Number 193675400
Status Registered
Filing Date 2018-12-18
Registration Date 2023-01-20
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations for use in oncology; pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, metabolic, respiratory, nervous, neurological, and gastrointestinal systems; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for the treatment of infection, namely anti-invective, and for the treatment of inflammation, namely anti-inflammatories; pharmaceutical preparations and substances, namely antibodies for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, antibodies for use in gastroenterology, antibodies for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity and hypothyroidism, antibodies for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases, antibodies for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances, namely therapeutic vaccines for humans for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, therapeutic vaccines for humans for use in gastroenterology, therapeutic vaccines for humans for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity and hypothyroidism, therapeutic vaccines for humans for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases, therapeutic vaccines for humans for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies.

52.

TRIVESPI

      
Application Number 191196900
Status Registered
Filing Date 2018-07-27
Registration Date 2020-02-20
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders and metabolic diseases and disorders; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatory; pharmaceutical preparations, namely, anti-infective

53.

BREZTRI

      
Application Number 190309800
Status Registered
Filing Date 2018-06-07
Registration Date 2023-10-12
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders and metabolic diseases and disorders; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatory; pharmaceutical preparations, namely, anti-infective

54.

POWMERU

      
Application Number 190267100
Status Registered
Filing Date 2018-06-05
Registration Date 2020-02-12
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

55.

PT010 Design

      
Application Number 190069600
Status Registered
Filing Date 2018-05-24
Registration Date 2020-02-20
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

56.

BREZALYNX

      
Application Number 187746000
Status Registered
Filing Date 2018-01-15
Registration Date 2023-05-23
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatory; pharmaceutical preparations, namely, anti-infective

57.

WINDESPI

      
Application Number 187749500
Status Registered
Filing Date 2018-01-15
Registration Date 2020-01-10
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatory; pharmaceutical preparations, namely, anti-infective

58.

Circle Design

      
Application Number 185463800
Status Registered
Filing Date 2017-08-28
Registration Date 2019-07-23
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

59.

ALOVICTRA

      
Application Number 185464000
Status Registered
Filing Date 2017-08-28
Registration Date 2019-07-09
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

60.

IMFINZI

      
Application Number 185467000
Status Registered
Filing Date 2017-08-28
Registration Date 2020-02-11
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

61.

BREKYNTRA

      
Application Number 185464800
Status Registered
Filing Date 2017-08-28
Registration Date 2019-07-11
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

62.

OMPRELTO

      
Application Number 185465000
Status Registered
Filing Date 2017-08-28
Registration Date 2019-08-13
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

63.

RILTRAVA

      
Application Number 185465800
Status Registered
Filing Date 2017-08-28
Registration Date 2019-08-14
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

64.

IFNARBYN

      
Application Number 184741300
Status Registered
Filing Date 2017-07-14
Registration Date 2019-07-23
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

65.

KEPSTRIVA

      
Application Number 184741600
Status Registered
Filing Date 2017-07-14
Registration Date 2019-08-13
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective.

66.

PERSIFNA

      
Application Number 184744800
Status Registered
Filing Date 2017-07-14
Registration Date 2019-08-13
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

67.

POCIENT

      
Application Number 184745100
Status Registered
Filing Date 2017-07-14
Registration Date 2019-08-13
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

68.

ZIFNELA

      
Application Number 184749900
Status Registered
Filing Date 2017-07-14
Registration Date 2019-08-20
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

69.

ARLISPO

      
Application Number 182171100
Status Registered
Filing Date 2017-02-07
Registration Date 2019-07-10
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for the prevention and treatment of respiratory diseases and disorders

70.

BENPLEOS

      
Application Number 182171000
Status Registered
Filing Date 2017-02-07
Registration Date 2019-07-10
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for the prevention and treatment of respiratory diseases and disorders

71.

CALQUENCE

      
Application Number 180665300
Status Registered
Filing Date 2016-10-27
Registration Date 2019-07-23
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

72.

BAKALVIO

      
Application Number 180665500
Status Registered
Filing Date 2016-10-27
Registration Date 2019-07-10
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

73.

BEVESPI Design

      
Application Number 180375300
Status Registered
Filing Date 2016-10-07
Registration Date 2019-07-10
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infectives

74.

FASENRA

      
Application Number 179627600
Status Registered
Filing Date 2016-08-17
Registration Date 2018-09-26
Owner ASTRAZENECA AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for the prevention and treatment of respiratory diseases and disorders.

75.

Fasenra Design

      
Application Number 179627800
Status Registered
Filing Date 2016-08-17
Registration Date 2018-09-26
Owner ASTRAZENECA AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for the prevention and treatment of respiratory diseases and disorders.

76.

PRYZODA

      
Application Number 179568400
Status Registered
Filing Date 2016-08-12
Registration Date 2019-07-03
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

77.

FIDURSI

      
Application Number 178397100
Status Registered
Filing Date 2016-05-25
Registration Date 2019-07-23
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

78.

TAGRISSO

      
Application Number 178401400
Status Registered
Filing Date 2016-05-25
Registration Date 2019-03-07
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology

79.

AEROSPHERE

      
Application Number 178340200
Status Registered
Filing Date 2016-05-20
Registration Date 2019-07-09
Owner ASTRAZENECA AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances, namely drug delivery agents in the form of liquid suspensions for administering drugs to the respiratory system.

80.

QTRENU

      
Application Number 176819600
Status Registered
Filing Date 2016-02-17
Registration Date 2019-06-19
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

81.

QTRIEN

      
Application Number 176819800
Status Registered
Filing Date 2016-02-17
Registration Date 2019-06-19
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

82.

QTERNMET

      
Application Number 176354100
Status Registered
Filing Date 2016-01-15
Registration Date 2019-08-13
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective.

83.

QTERNAMET

      
Application Number 176354300
Status Registered
Filing Date 2016-01-15
Registration Date 2019-08-13
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective.

84.

BYTIVITI

      
Application Number 176353200
Status Registered
Filing Date 2016-01-15
Registration Date 2019-07-23
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective.

85.

QTERMET

      
Application Number 174867700
Status Registered
Filing Date 2015-10-01
Registration Date 2019-08-13
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely anti-inflammatories; pharmaceutical preparations, namely anti-infectives.

86.

UBYDEO

      
Application Number 174461600
Status Registered
Filing Date 2015-09-03
Registration Date 2019-08-20
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely anti-inflammatories; pharmaceutical preparations, namely anti-infectives.

87.

QUARIPTIS

      
Application Number 174322300
Status Registered
Filing Date 2015-08-25
Registration Date 2019-08-14
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infectives.

88.

BYDALAZ

      
Application Number 173935700
Status Registered
Filing Date 2015-07-28
Registration Date 2019-07-09
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely anti-inflammatory; pharmaceutical preparations, namely anti-infective.

89.

BYXTENDIA

      
Application Number 173935800
Status Registered
Filing Date 2015-07-28
Registration Date 2019-07-09
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely anti-inflammatory; pharmaceutical preparations, namely anti-infective.

90.

ZEMFIRZA

      
Application Number 173252500
Status Registered
Filing Date 2015-06-11
Registration Date 2019-08-20
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective.

91.

BYAMPI

      
Application Number 173208800
Status Registered
Filing Date 2015-06-09
Registration Date 2019-07-12
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders

92.

VEGDURIS

      
Application Number 173208900
Status Registered
Filing Date 2015-06-09
Registration Date 2019-08-20
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective

93.

ONAMPI

      
Application Number 173161200
Status Registered
Filing Date 2015-06-05
Registration Date 2019-08-13
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective.

94.

VELVESP

      
Application Number 173161100
Status Registered
Filing Date 2015-06-05
Registration Date 2019-08-20
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective.

95.

TEMLIMM

      
Application Number 173121900
Status Registered
Filing Date 2015-06-03
Registration Date 2019-08-20
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective.

96.

OCYTLA

      
Application Number 173122000
Status Registered
Filing Date 2015-06-03
Registration Date 2019-08-13
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective.

97.

APJULI

      
Application Number 173122200
Status Registered
Filing Date 2015-06-03
Registration Date 2019-07-10
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective.

98.

IMJUDO

      
Application Number 173122300
Status Registered
Filing Date 2015-06-03
Registration Date 2019-07-23
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective.

99.

IMCEPSEO

      
Application Number 173122400
Status Registered
Filing Date 2015-06-03
Registration Date 2019-07-23
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology and for the treatment of cardiovascular diseases and disorders, respiratory diseases and disorders, pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, anemia, obesity and hypothyroidism; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, depression, anxiety, central nervous system movement disorders, and spinal cord diseases; pharmaceutical preparations and substances for the treatment of diseases and disorders of the peripheral nervous system, namely cranial and spinal neuropathies, autonomic neuropathies, sensorimotor neuropathies and plexopathies; pharmaceutical preparations and substances for use in pain control and local and general anesthetics; pharmaceutical preparations, namely, anti-inflammatories; pharmaceutical preparations, namely, anti-infective.

100.

IMFINZI

      
Application Number 173122500
Status Registered
Filing Date 2015-06-03
Registration Date 2018-06-06
Owner AstraZeneca AB (Sweden)
NICE Classes  ? 05 - Pharmaceutical, veterinary and sanitary products

Goods & Services

(1) Pharmaceutical preparations and substances for use in oncology.
  1     2        Next Page